Opioid Induced Constipation Treatment Market

Posted by ahila on April 26th, 2018

Opioids are the drugs used for its pain relieving properties in non-cancer and chronic pain. The adverse effects associated with the opioids are decreasing gastrointestinal tract’s motility, making patient’s strain, and making of solid discharges. Furthermore, long-term use of opioids cause harm to the sensory system, limits the release of endogenous opioids such as endorphins. Adults are most likely to prone to opioid-induced constipation owing to less immobility, poor diet, and fluid intake. The symptoms associated with the opioid-induced constipation are included dry and hard tools, leathery feeling, painful defecation, bulged abdomen, and loss of appetite.

The opioid-induced constipation treatment market growing at a significant CAGR due to rise in the aging population using opioid analgesics for chronic pains. Increase in the illicit use of medications, prolonged usage of opioids in the treatment of pain, and increase in the prevalence of cancer are anticipated to boost the global opioid-induced constipation treatment market. Furthermore, launching of newer drugs, growing FDA approvals, positive outcomes in clinical trials, and rise in the healthcare expenditure are expected to propel the opioid-induced constipation treatment market over the forecast period. However, lack of awareness regarding opioid-induced constipation in patients, the absence of treatment innovations, high cost of newer pharmaceuticals, adverse effects, including nausea, risk of heart problems and strokes associated with these drugs and unfavorable reimbursement policies expected to hamper the growth of the opioid-induced constipation treatment market.

A sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-opioid-induced-constipation-treatment-market/#ulp-4H8Z4LpNMLEuOnnx

The opioid-induced constipation treatment market is segmented on the basis of drug type, formulation type, route of administration, and distribution channel

Based on drug type, opioid induced constipation treatment market has been segmented into the following

• Peripherally restricted μ-opioid receptor antagonists
• Non-selective opioid antagonists
• μ -opioid receptor antagonists
• Locally acting chloride channel activators

Based on formulation type, opioid-induced constipation treatment market has been segmented into the following

• Solids
• Semi-solids
• Liquids

Based on route of administration, opioid-induced constipation treatment market has been segmented into the following

• Oral
• Parenteral (Subcutaneous Injection)

Based on distribution channel, opioid-induced constipation treatment market has been segmented into the following

• Drug store
• Retail pharmacies
• Hospital pharmacies

To view TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/global-opioid-induced-constipation-treatment-market/#ulp-c654SbFYO64MsOhu